The relationship between stroke and sleep, including both quantity and quality, is complex. Previous research has indicated that both sleep deprivation and sleeping for more than 9 hours a day can increase the risk of stroke, and experiencing a stroke can also cause changes in sleeping patterns.
Insomnia
Insomnia is a classification of sleep disorders in which a person has trouble falling asleep, staying asleep or waking up too early. These disorders may also be defined by an overall poor quality of sleep. Insomnia is the most commonly reported sleep disorder. About 30 percent of adults have symptoms of insomnia. On average, most adults need seven to eight hours of sleep each night to feel alert and well-rested.
Epidiolex derived from marijuana to treat epilepsy
The U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of
Sleep apnea common after acute respiratory failure
Sleep apnea is common after acute respiratory failure – Clinically important sleep apnea is common among survivors of acute respiratory failure. Insomnia is a frequent complaint among survivors of critical illness.
Mind wandering may lead to insomnia
Brain imaging study reveals the wandering mind behind insomnia — Study is the first to find functional MRI differences in working memory in people with primary insomnia – A new brain imaging study may help explain why people with insomnia often complain that they struggle to concentrate during the day even when objective evidence of a cognitive problem is lacking.
Regular long term exercise is good for sleep
Exercise is no quick cure for insomnia – Hitting the treadmill today won’t help you sleep tonight; it takes 4 months to kick in – Exercise is a common prescription for insomnia. But spending 45 minutes on the treadmill one day won’t translate into better sleep that night. “If you have insomnia you won’t exercise yourself into sleep right away,” said lead study author Kelly Glazer Baron, a clinical psychologist and director of the behavioral sleep program at Northwestern University Feinberg School of Medicine.
Qsymia approved for chronic weight management
U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management – The U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management.
Poor sleep habits increases fibromyalgia risk in middle aged and older women
Poor sleep habits linked to increased risk of fibromyalgia in women — Middle-aged and older women with sleep problems are at greater risk – Researchers from Norway have uncovered an association between sleep problems and increased risk of fibromyalgia in women. The risk of fibromyalgia increased with severity of sleep problems, and the association was stronger among middle-aged and older women than among younger women.
Wives’ inability to fall asleep at night has interpersonal consequences in marriage
Study finds that wives’ sleep problems have negative impact on marital interactions — Wives’ inability to fall asleep at night has interpersonal consequences in marriage – The quality of interactions among married couples is affected by wives’ inability to fall asleep at night, but not by husbands’ sleep problems, suggests new research presented in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS). Results show that, among wives, taking longer to fall asleep at night predicted their reports of more negative and less positive marital interactions the next day.
Antidepressants may not improve all symptoms of depression
Antidepressants may not improve all symptoms of depression, UT Southwestern researchers find – Even people who show a clear treatment response with antidepressant medications continue to experience symptoms like insomnia, sadness and decreased concentration, researchers at UT Southwestern Medical Center have found after analyzing data from the largest study on the treatment of depression.
QNEXA for Weight Loss in obesity – CONQUER study
QNEXA? Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities – VIVUS, Inc. (NASDAQ: VVUS) announced that detailed results from the 56-week CONQUER study were published in The Lancet evaluating the efficacy and safety of investigational drug QNEXA in 2,487 patients across 93 sites in the US.